BioCentury | Nov 9, 2019
Product Development

Amgen to accelerate China strategy via BeiGene deal

...China was with Betta Pharmaceuticals Co. Ltd. (SZSE:300558), which markets Amgen's colorectal cancer drug Vectibix panitumumab...
BioCentury | Nov 27, 2018
Distillery Therapeutics

Cancer

...Inc., Takeda Pharmaceutical Co. Ltd. and Dr. Reddy’s Laboratories Ltd. market the anti-EGFR mAb Vectibix panitumumab...
BioCentury | Sep 26, 2018
Distillery Techniques

Assays and screens; other

...for clinical progression. In nine mCRC patients receiving the anti-EGFR mAbs Erbitux cetuximab or Vectibix panitumumab...
...testing for adenocarcinoma. Amgen Inc., Takeda Pharmaceutical Co. Ltd. and Dr. Reddy’s Laboratories Ltd. market Vectibix...
...Nicola Valeri, The Institute of Cancer Research, Sutton, U.K. email: andrea.sottoriva@icr.ac.uk Claire Quang Erbitux, cetuximab (IMC-C225) Vectibix, panitumumab (ABX-EGF) The...
BioCentury | Sep 14, 2018
Company News

GNS, Amgen to use AI to explore patient response to mCRC drug Vectibix

...identify factors that drive and predict patient responses to Amgen’s metastatic colorectal cancer (mCRC) Vectibix panitumumab...
...Amgen's Phase II PEAK trial and the alliance's Phase III CALGB 80405 trial. PEAK compared Vectibix...
...Thousand Oaks, Calif. Alliance for Clinical Trials in Oncology, Boston, Mass. Business: Cancer Shannon Lehnbeuter Vectibix, panitumumab (ABX-EGF) Amgen...
BioCentury | Aug 17, 2018
Finance

Location, location, biotech

...cap is now RMB17.2 billion ($2.5 billion). Betta also markets Amgen Inc.’s anti-EGFR mAb Vectibix panitumumab...
BioCentury | Jan 4, 2018
Strategy

Next generation resolutions

...and neuroblastoma Ras viral oncogene (NRAS) exons 2, 3 and 4) in tumor tissue Vectibix panitumumab...
BioCentury | Sep 29, 2017
Company News

Amgen, Simcere partner for biosimilars in China

...Ltd. (SZSE:300558) -- Amgen-Betta Pharmaceuticals Co. Ltd. -- to commercialize Amgen's colorectal cancer drug Vectibix panitumumab...
BioCentury | Sep 27, 2017
Company News

Amgen, Simcere partner for biosimilars in China

...Ltd. (SZSE:300558) -- Amgen-Betta Pharmaceuticals Co. Ltd. -- to commercialize Amgen's colorectal cancer drug Vectibix panitumumab...
BioCentury | Sep 1, 2017
Company News

Betta, Tyrogenex form JV for RCC candidate

...a JV -- Amgen-Betta Pharmaceuticals Co. Ltd. -- to commercialize Amgen's colorectal cancer drug Vectibix panitumumab...
BioCentury | Aug 28, 2017
Company News

Betta, Tyrogenex form JV for RCC candidate

...a JV -- Amgen-Betta Pharmaceuticals Co. Ltd. -- to commercialize Amgen's colorectal cancer drug Vectibix panitumumab...
Items per page:
1 - 10 of 411